Last day at #ISLB24, many great abstracts presentations here in Denver! @ReduzziCarol @eleonora_nicolo @ddemiguelperez @ChristianRolfo @UmbertoMalapel1 @CarloGenova5 @MariantoniaNac1 @isliquidbiopsy @MJOSESERRANO19

Three incredible days of #ISLB24 congress have come to an end! It’s been a pleasure meeting and discussing with so many experts in liquid biopsy🩸 Honored to be part of this society—only by sharing knowledge and experience can we truly advance the field! @isliquidbiopsy

Our @isliquidbiopsy young committee is leading the last session of the day at #ISLB24 the Round Tables discussing career development and mentoring for #liquidbiopsy experts Great lineup of speakers @ReduzziCarol @HeekeSimon @RobertoBoreaMD @ddemiguelperez @BrunaPellini @mgoudaMD

Today we launched the "ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy" to collect worldwide data on the use of liquid biopsy in clinical practice! Help us sharing the survey with all the oncologists you know :) https://t.co/UfwHSj5Pn3

@ogarrieta @ChristianRolfo @fred_hirsch @AndresFCardonaZ @Al3ssandroRusso @SusmitaSahooPhD @IcahnMountSinai @OhioState @UMBaltimore

Thanks to all the authors that made possible this exciting research. @ogarrieta @ChristianRolfo @fred_hirsch @AndresFCardonaZ @Al3ssandroRusso @SusmitaSahooPhD and more. @IcahnMountSinai @OhioState @UMBaltimore INCAN Mexico

It's finally out! Our last article in liquid biopsy: SARS-COV-2 proteins are transported into extracellular vesicles and they reveal shorter survival and inflammatory, respiratory and cardiac complications in patients with Severe COVID-19. https://t.co/NFaUUdukv9

Happy to announce that I just started a new position as a Research Assistant Professor at The Ohio State University, continuing my efforts on the research of liquid biopsy biomarkers in cancer patients. 👨‍🔬 👨‍🏫 💉 🔬

Out now on @CHematology the @isliquidbiopsy review on 20 years of CTC research! https://t.co/wS6DrUOSWv @MCristofanill @ChristianRolfo @MJOSESERRANO19 @drgandara @UmbertoMalapel1 @NicolaFuscoMD @AngeloDipa_

Most lung cancer screening programs primarily target subjects with a history of smoking as the leading risk factor. Our recently published review discusses risk prediction models to optimize screening in non-smokers to accurately identify individuals who should be included in

🤩🔥Delighted to share our editorial with this stellar team, talking about the role of liquid biopsy in the sustained progression of precision oncology. Also highlighted in the presentation by our committee chair @ReduzziCarol today at the @isliquidbiopsy 20th year anniversary

Very proud of @ddemiguelperez presenting our work in Extracellular Vesicles in COVID19 at @NIH #liquidbiopsy Conference A great team effort in collaboration with @ogarrieta @incanMX @TischCancer @IcahnMountSinai @isliquidbiopsy

Happy to share our lastest review on the potential uses of engineered extracellular vesicles in cancer therapeutics! The result of combined efforts with Marina Perez-Capo and Antonia Obrador-Hevia from @idisbaib and @ChristianRolfo @IcahnMountSinai https://t.co/dd3wy6MQoa

Proud of @ddemiguelperez presenting our work EV and COVID19 at Seronet @NIH @theNCI A pilot study from a prospective trial Tocilizumab in severe COVID. Using dynamics of EVs, viral prot & other analysis we found important correlations. Stay tuned for the paper @TischCancer

Be part of the 20th Anniversary of Circulating Tumor Cells, organized by ISLB! 📅 Save the date for May 24 - 25, 2024, and join us as we unveil the impact of Circulating Tumor Cells, exploring two decades of discovery and clinical advancements in solid tumors. Chairs:

Excited to share our article in @Annals_Oncology about Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)! @MDAndersonNews @isliquidbiopsy https://t.co/buesuvf9MD

Proud to share our latest research on Genomic profiling of tissue and blood in resected pleural mesothelioma published in European Journal of Cancer. Thanks again to this team to make it possible! @ChristianRolfo @UmbertoMalapel1 @Al3ssandroRusso et al. https://t.co/StYc5cfU2V

📣Our paper “Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma” is online now! @ElsevierConnect @ddemiguelperez @Al3ssandroRusso @TischCancer @IcahnMountSinai @MSHSThoracicOnc @curemeso https://t.co/GdDWBGSenk

Great panel of experts for the section “Integrating LB into composite biomarkers” @ddemiguelperez @ElJanLe @FabioPagni1 @MCristofanill @drgandara Natasha Leighl! #ISLB23 @isliquidbiopsy

Preferred Abstracts : after the discussants take home message we have a plus of discussion due to the important data presented! @jamiefeng @blood_pac @ddemiguelperez @ReduzziCarol @Al3ssandroRusso #ISLB23 @isliquidbiopsy